As of 2025-04-22, the Relative Valuation of Edgewise Therapeutics Inc (EWTX) is (21.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.30 USD, the upside of Edgewise Therapeutics Inc based on Relative Valuation is -259.4%.
The range of the Relative Valuation is (19.13) - (23.17) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 18.1x | 16.4x |
| Forward P/E multiples | 14.5x - 19.3x | 16.8x |
| Fair Price | (19.13) - (23.17) | (21.20) |
| Upside | -243.9% - -274.2% | -259.4% |
| Date | P/E |
| 2025-04-21 | -10.62 |
| 2025-04-17 | -10.53 |
| 2025-04-16 | -10.20 |
| 2025-04-15 | -10.19 |
| 2025-04-14 | -9.65 |
| 2025-04-11 | -8.94 |
| 2025-04-10 | -9.06 |
| 2025-04-09 | -9.79 |
| 2025-04-08 | -9.00 |
| 2025-04-07 | -9.26 |
| 2025-04-04 | -9.01 |
| 2025-04-03 | -10.63 |
| 2025-04-02 | -12.15 |
| 2025-04-01 | -15.76 |
| 2025-03-31 | -17.23 |
| 2025-03-28 | -18.22 |
| 2025-03-27 | -18.35 |
| 2025-03-26 | -17.43 |
| 2025-03-25 | -17.85 |
| 2025-03-24 | -18.30 |
| 2025-03-21 | -18.49 |
| 2025-03-20 | -18.65 |
| 2025-03-19 | -19.25 |
| 2025-03-18 | -20.77 |
| 2025-03-17 | -20.69 |
| 2025-03-14 | -20.10 |
| 2025-03-13 | -19.79 |
| 2025-03-12 | -19.72 |
| 2025-03-11 | -21.45 |
| 2025-03-10 | -21.55 |
| 2025-03-07 | -21.93 |
| 2025-03-06 | -22.02 |
| 2025-03-05 | -20.91 |
| 2025-03-04 | -19.18 |
| 2025-03-03 | -19.99 |
| 2025-02-28 | -20.49 |
| 2025-02-27 | -20.66 |
| 2025-02-26 | -20.02 |
| 2025-02-25 | -19.64 |
| 2025-02-24 | -19.58 |
| 2025-02-21 | -21.19 |
| 2025-02-20 | -21.22 |
| 2025-02-19 | -20.88 |
| 2025-02-18 | -20.46 |
| 2025-02-14 | -19.88 |
| 2025-02-13 | -20.37 |
| 2025-02-12 | -20.24 |
| 2025-02-11 | -20.48 |
| 2025-02-10 | -20.62 |
| 2025-02-07 | -20.65 |